CAR-T Therapy

CAR-T therapy engineers T cells to attack cancer; focus on auto/allo and targets.The sector's total market cap is 1554.28 billion USD, with a 24h change of +0.76%. Among 7 constituents, 7 are up (100.00%) and 0 are down (0%). The top gainer is GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK), with a 24h increase of +1.20%.CAR-T steady; breadth mixed. Favor leaders; be selective.
Name
Last Price
change.pct2
Last Price / change.pct2
price.trend.chart
price.price.band
Action
JNJ
JNJJohnson & Johnson
266.01$269.95
+0.98%
+1.48%
ah.trading
266.01
+0.98%
฿264.75฿268.36
AMGN
AMGNAmgen Inc
376.09$377.00
+0.01%
+0.24%
ah.trading
376.09
+0.01%
฿376.08฿381.60
PFE
PFEPfizer Inc.
24.67$24.68
+0.48%
+0.04%
ah.trading
24.67
+0.48%
฿24.62฿24.84
GILD
GILDGilead Sciences Inc
130.49$130.58
+0.89%
+0.06%
ah.trading
130.49
+0.89%
฿130.49฿132.51
GSK
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)
51.97$51.98
+1.20%
+0.01%
ah.trading
51.97
+1.20%
฿51.90฿52.47
INCY
INCYIncyte Genomics Inc
118.93$118.00
+1.07%
-0.78%
ah.trading
118.93
+1.07%
฿118.93฿120.00
NVS
NVSNovartis AG
156.11$156.11
+0.71%
0.00%
ah.trading
156.11
+0.71%
฿156.11฿157.59